Arcellx, Inc. Common Stock (ACLX)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Headquarters
- United States
- Employees
- 209
- Market Cap
- $6.7B
About Arcellx, Inc. Common Stock
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
SentiSense also tracks daily options readings for Arcellx, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Arcellx, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.